Encara no tenim significats per a "patient survival".
1Thus, accurate prognostic model for patient survival and treatment decision is demanded.
2There was no difference in patient survival between study and control groups.
3Similar findings were observed regardless of tumor histology and patient survival time.
4These interpretations were compared with surgical findings, clinical course and patient survival.
5Rates of BCAR, graft survival, and patient survival were similar between groups.
6Conclusions: Aggressive management of recurrent HCC after upfront LR improves patient survival.
7The first stage validation confirmed a signature's ability to stratify patient survival.
8Expression of S-FN did not have a significant effect on patient survival.
9There were no significant differences regarding patient survival between the two groups.
10Repeat transplantation was associated with a substantial improvement in 5-year patient survival.
11Most importantly, high PMEPA1 mRNA levels were associated with lower patient survival.
12In addition the importance of tumor remission for patient survival was analyzed.
13Statistical analysis revealed no significant correlation between PCNA index and patient survival.
14Correlations of FN expression with clinicopathologic factors and patient survival were investigated.
15Very few differences in patient survival are observed between males and females.
16HER2 status or primary tumor site did not correlate with patient survival.
Aquesta col·locació està formada per:
Patient survival a través del temps
Patient survival per variant geogràfica